½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1459772

µÎ°³³» ½ºÅÙÆ® ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2031³â)

Intracranial Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 152 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µÎ°³³» ½ºÅÙÆ® ½ÃÀå - Á¶»ç ¹üÀ§

TMRÀÇ Á¶»ç º¸°í¼­ "¼¼°è µÎ°³³» ½ºÅÙÆ® ½ÃÀå"Àº 2023³âºÎÅÍ 2031³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» ¾ò±â À§ÇØ °ú°Å»Ó¸¸ ¾Æ´Ï¶ó ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ Á¶»çÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ¿¬µµ·Î, 2031³âÀ» ¿¹Ãø ¿¬µµ·Î °£ÁÖÇÏ¿© 2017³âºÎÅÍ 2031³â±îÁöÀÇ ¼¼°è µÎ°³³» ½ºÅÙÆ® ½ÃÀåÀÇ ¼öÀÍ°ú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ 2023³âºÎÅÍ 2031³â±îÁö ¼¼°è µÎ°³³» ½ºÅÙÆ® ½ÃÀåÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)µµ Á¦½ÃÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±¤¹üÀ§ÇÑ 1Â÷ Á¶»ç, KOL(Key Opinion Leader), ¾÷°è ¸®´õ ¹× ¿ÀÇǴϾð Á¦Á¶¾÷ü¿ÍÀÇ ÀÎÅͺä, ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ÀÚ·á, ¿¬·Ê º¸°í¼­, º¸µµ ÀÚ·á, °ü·Ã ¹®¼­ µîÀ» ÂüÁ¶ÇÏ¿© µÎ°³³» ½ºÅÙÆ® ½ÃÀåÀ» ÆľÇÇϱâ À§ÇÑ 2Â÷ Á¶»ç¸¦ ÅëÇØ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. ÆľÇÇß½À´Ï´Ù.

½ÃÀå ÇöȲ
2022³â ½ÃÀå °¡Ä¡ 22¾ï ´Þ·¯
2031³â ½ÃÀå °¡Ä¡ 34¾ï ´Þ·¯
CAGR 5.2%

ÀÌ º¸°í¼­´Â ¼¼°è µÎ°³³» ½ºÅÙÆ® ½ÃÀåÀÇ °æÀï ȯ°æÀ» Á¶»çÇß½À´Ï´Ù. ¼¼°è µÎ°³³» ½ºÅÙÆ® ½ÃÀå¿¡¼­ È°µ¿ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÌ È®ÀεǾúÀ¸¸ç, °¢ ±â¾÷µéÀº ´Ù¾çÇÑ ¼Ó¼ºÀ¸·Î ÇÁ·ÎÆÄÀϸµµÇ¾ú½À´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óÅÂ, ÃÖ±Ù ½ÃÀå °³¹ß ¹× SWOT´Â ÀÌ º¸°í¼­¿¡ ¼Ò°³µÈ ¼¼°è µÎ°³³» ½ºÅÙÆ® ½ÃÀå ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼­·Ð
  • ½ÃÀå °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø, 2017-2031³â

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • ÁÖ¿ä Á¦Ç°/ºê·£µå ºÐ¼®
  • ÁÖ¿ä M&A
  • COVID-19 ÆÒµ¥¹ÍÀÇ »ê¾÷¿¡ ´ëÇÑ ¿µÇâ

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° À¯Çüº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Á¦Ç° À¯Çüº°, 2017³â-2031³â
    • ÀÚ±â È®ÀåÇü ½ºÅÙÆ®
    • dz¼± È®Àå ½ºÅÙÆ®
    • ½ºÅÙÆ® Áö¿ø ÄÚÀÏ»öÀü¼ú
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç° À¯Çüº°

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÀûÀÀ Áúȯº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ÀûÀÀ Áúȯº°, 2017³â-2031³â
    • µÎ°³³» ÇùÂø
    • ³úµ¿¸Æ·ù
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÀûÀÀ Áúȯº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2017³â-2031³â
    • º´¿ø
    • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Áö¿ªº°, 2017³â-2031³â
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦10Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå °æÀï ¸ÅÆ®¸¯½º(Tierº°, ±â¾÷ ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°(2022³â)
  • ±â¾÷ °³¿ä
    • Penumbra, Inc.
    • Medtronic
    • Stryker Corporation
    • Boston Scientific Corporation
    • Johnson & Johnson Services, Inc.
    • Cook Medical
LSH 24.05.17

Intracranial Stents Market - Scope of Report

TMR's report on the global intracranial stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global intracranial stents market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global intracranial stents market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the intracranial stents market.

Market Snapshot
Market Value in 2022US$ 2.2 Bn
Market Value in 2031US$ 3.4 Bn
CAGR5.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global intracranial stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global intracranial stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global intracranial stents market.

The report delves into the competitive landscape of the global intracranial stents market. Key players operating in the global intracranial stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global intracranial stents market profiled in this report.

Key Questions Answered in Global intracranial stents Market Report:

  • What is the sales/revenue generated by intracranial stents across all regions during the forecast period?
  • What are the opportunities in the global intracranial stents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Intracranial Stents Market - Research Objectives and Research Approach

The comprehensive report on the global intracranial stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global intracranial stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global intracranial stents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Intracranial Stents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Intracranial Stents Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Intracranial Stents Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Self-expanding Stents
    • 6.3.2. Balloon Expanding Stents
    • 6.3.3. Stent-assisted Coil Embolization
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Intracranial Stents Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Intracranial Stenosis
    • 7.3.2. Brain Aneurysm
  • 7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Intracranial Stents Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Intracranial Stents Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Intracranial Stents Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2017-2031
    • 10.3.1. Self-expanding Stents
    • 10.3.2. Balloon Expanding Stents
    • 10.3.3. Stent-assisted Coil Embolization
  • 10.4. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.4.1. Intracranial Stenosis
    • 10.4.2. Brain Aneurysm
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Hospitals
    • 10.5.2. Ambulatory Surgical Centers
    • 10.5.3. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type
    • 10.7.2. By Disease Indication
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Intracranial Stents Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2017-2031
    • 11.3.1. Self-expanding Stents
    • 11.3.2. Balloon Expanding Stents
    • 11.3.3. Stent-assisted Coil Embolization
  • 11.4. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.4.1. Intracranial Stenosis
    • 11.4.2. Brain Aneurysm
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Ambulatory Surgical Centers
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Disease Indication
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Intracranial Stents Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2017-2031
    • 12.3.1. Self-expanding Stents
    • 12.3.2. Balloon Expanding Stents
    • 12.3.3. Stent-assisted Coil Embolization
  • 12.4. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.4.1. Intracranial Stenosis
    • 12.4.2. Brain Aneurysm
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Ambulatory Surgical Centers
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Disease Indication
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Intracranial Stents Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product Type, 2017-2031
    • 13.3.1. Self-expanding Stents
    • 13.3.2. Balloon Expanding Stents
    • 13.3.3. Stent-assisted Coil Embolization
  • 13.4. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.4.1. Intracranial Stenosis
    • 13.4.2. Brain Aneurysm
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Ambulatory Surgical Centers
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Disease Indication
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Intracranial Stents Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product Type, 2017-2031
    • 14.3.1. Self-expanding Stents
    • 14.3.2. Balloon Expanding Stents
    • 14.3.3. Stent-assisted Coil Embolization
  • 14.4. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.4.1. Intracranial Stenosis
    • 14.4.2. Brain Aneurysm
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Ambulatory Surgical Centers
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Disease Indication
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Penumbra, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Medtronic
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Stryker Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Boston Scientific Corporation
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Johnson & Johnson Services, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Cook Medical
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦